Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.01, 2.03, 9.01 · 8-K

SS Innovations International Inc.

SSIINASDAQEQUITYCurrent

Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Item 1.01 Entry into a Material Definitive Agreement. Securities Purchase Agreement On October 9, 2026 (the “Closing Date” or the “Effective Date”), SSi entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”), and consummated the transactions contemplated thereby (the “Closing”).…

Filed Oct 13, 2026Accepted Oct 13, 2026, 6:05 AM EDTCIK 1676163Accession 0001213900-26-108624
Share

Company context

SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. Headquartered in India, SS Innovations is a U.S. company focused on expanding the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.

Current securities

Historical securities (3)

Recent company filings

  1. Other EventsOct 13, 2026
  2. 4 filingOct 9, 2026
  3. 424B5 filingOct 9, 2026
  4. Regulation FD DisclosureOct 5, 2026
  5. Other EventsSep 10, 2026

Registered securities in this filing

SS INNOVATIONS INTERNATIONAL, INC. · 8-K · Filed 2026-10-13

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock

Symbol
SSII
Exchange
NASDAQ
Classification
COMMON
Filing context

Context: AsOf2026-10-09

Dimensions: Not supplied

Accession 000121390026108624 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.01, 2.03, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01 Entry into a Material Definitive Agreement. Securities Purchase Agreement On October 9, 2026 (the “Closing Date” or the “Effective Date”), SSi entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an institutional investor (the “Investor”), and consummated the transactions contemplated thereby (the “Closing”). Pursuant to the Purchase Agreement, the Company issued and sold to the Investor a secured convertible promissory note in the original principal amount of $21,025,000 (the “Note”), which is convertible into shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”), for an aggregate purchase price of $20,000,000. The Common Shares issuable upon conversion of or otherwise pursuant to the Note are referred to herein as the “Conversion Shares.” In connection with the Closing, the Company filed a prospectus supplement pursuant to Rule 424(b) under the Securities Act of 1933, as amended, to the Company’s effective shelf registration statement on Form S-3 (File No. 333-295501), covering the offer and sale of the Note and the Conversion Shares. The Company also established an initial reserve of 8,000,000 Common Shares for issuances of Conversion Shares under the Note (the “Share Reserve”) and agreed to increase the Share Reserve in increments of 100,000 Common Shares as required under the Purchase Agreement. The Purchase Agreement contains customary representations, warranties and covenants of the Company and the Investor. The Note The Note has an original principal amount of $21,025,000 and was issued for a purchase price of $20,000,000. The additional $1,025,000 included in the principal amount represents original issue discount of $1,000,000 and the Investor’s transaction expenses of $25,000. The Note bears interest at a rate of 8.75% per annum compounded daily and matures thirty-six (36) months after the Closing Date. The Note is secured by a security interest in (a) the Company’s intellectual property, which is held by SSI IP Holdings, Inc., a wholly-owned Delaware subsidiary of the Company (“SS IP”), pursuant to an Intellectual Property Security Agreement by and between the Investor and SS IP (the “IP Security Agreement”); and (b) the assets of the Company and SS IP, including the Company’s equity interests in its direct and indirect subsidiaries, pursuant to a Security Agreement by and among the Investor, the Company and SS IP (the “Asset Security Agreement”). Notwithstanding the foregoing, the assets and capital stock of Sudhir Srivastava Innovations Pvt. Ltd., the Company’s Indian operating subsidiary (“SSI-India”), are excluded from the collateral securing the Note. The Note is also guaranteed by the Company’s direct and indirect subsidiaries other than SSI-India, pursuant to a Guaranty by and among the Investor and the guarantors entered into at the Closing. Commencing on the Effective Date, the Investor may convert all or any portion of the outstanding balance of the Note (which includes accrued but unpaid interest and certain other costs specified in the Note) into Common Shares at a conversion price equal to ninety-five percent (95%) of the Market Price (a “Limited Redemption”), provided that the trading price for the Common Shares on such date exceeds the Market Price by at least ten percent (10%). “Market Price” as defined in the Note means the lower of (a) the daily volume-weighted average price (“VWAP”) of the Common Shares for the trading day immediately preceding the date of measurement; and (b) the average daily VWAP for the Common Shares for the five (5) trading days immediately preceding the date of measurement (the “Limited Redemption Window”). Limited Redemptions are subject to a daily limit equal to the greater of (a) $50,000; and (b) ten percent (10%) of the cumulative daily dollar trading volume of the Common Shares on the trading day that a Limited Redemption occurs. Beginning on the twelve (12) month anniversary of the Effective Date, the Investor shall have the right, exercisable at any time in its sole and absolute discretion, to redeem all or any portion of the Note (such amount, the “Redemption Amount”), subject to a monthly limit equal to the outstanding balance of the Note as of the twelve (12) month anniversary of the Effective Date divided by twenty-four (24) (a “Fixed Redemption”). Payments of each Redemption Amount may be made, in the Company’s discretion, (a) in cash; (b) by converting such Redemption Amount into Conversion Shares (each, a “Redemption Conversion”) per the following formula: the number of Conversion Shares equals the portion of the applicable Redemption Amount being converted plus Make-Whole Interest (as hereinafter defined) on such amount divided by the Conversion Price; or (c) by any combination of the foregoing. 1 Upon five (5) trading days’ prior written notice, the Company may prepay all or any portion of the outstanding balance of the Note, other than any portion for which the Investor has delivered or elects to deliver a conversion notice prior to the expiration of such period and the applicable Conversion Shares have not yet been delivered. Each amount converted, redeemed or prepaid under the Note includes Make-Whole Interest. Notwithstanding the foregoing, in the event the average daily VWAP for each day during a Limited Redemption Window is fifteen percent (15%) or greater than the Minimum Price as defined in Nasdaq Rule 5635(d), on the day a Limited Redemption is made, applicable Make-Whole Interest will be reduced from the outstanding balance of the Note. As used in the Note, “Make-Whole Interest” means: (a) during the period beginning on the Effective Date and ending on the one (1) year anniversary of the Effective Date, all interest that has accrued and any remaining interest that would have accrued on the amount being paid or converted calculated as if such amount had been held to the Maturity Date; (b) during the period beginning on the first day after the one (1) year anniversary of the Effective Date and ending on the two (2) year anniversary of the Effective Date, all interest that has accrued and 66.66% of any remaining interest that would have accrued on the amount being paid or converted calculated as if such amount had been held to the Maturity Date; and (c) during the period beginning on the first day following the two (2) year anniversary of the Effective Date until this Note is paid in full, all interest that has accrued and 33.33% of all interest that would have accrued on the amount being paid or converted calculated as if such amount had been held to the Maturity Date. The Note is subject to a beneficial ownership limitation that prohibits any conversion to the extent that, after giving effect to the conversion, the Investor and its affiliates would beneficially own more than 4.99% of the Company’s outstanding Common Shares, which percentage may be increased by the Investor to 9.99% upon 61 days’ prior written notice. In addition, the cumulative number of Common Shares issued to the Investor pursuant to conversions of the Note, may not exceed the limitations imposed by Nasdaq Listing Rule 5635(d) (the “Exchange Cap”) unless and until the Company obtains shareholder approval for issuances in excess of the Exchange Cap or the Exchange Cap is otherwise inapplicable. The Note contains customary covenants of the Company and events of default. The foregoing descriptions of the Purchase Agreement, the Note, the IP Security Agreement, the Asset Security Agreement and the Guaranty Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of such agreements, copies of which are filed as Exhibits 10.1, 4.1, 10.2, 10.3 and 10.4 respectively, to this Current Report and are incorporated herein by reference. The legal opinion, including the related consent, of Lewis Brisbois Bisgaard & Smith LLP relating to the issuance of the Note and the Conversion Shares is filed as
Item 2.03Item 2.03 - Creation of Direct Financial Obligation
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The disclosure contained in
Filed exhibits (1)
EX-4.1 (by filename) ea030806201ex4-1.htm

Exhibit 4.1 SECURED CONVERTIBLE PROMISSORY NOTE October 9, 2026 U.S. $21,025,000.00 FOR VALUE RECEIVED, SS Innovations International, Inc., a Florida corporation (“Borrower”), promises to pay to Growth Capital Partners, LLC, a Utah limited liability company, or its successors or assigns (“Lender”), $21,025,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is thirty-six (36) months after the Purchase Price Date (as defined below) (the “Maturity Date”) in accordance with the terms set forth herein and to pay interest on the Outstanding Balance at the rate of eight and three-fourths percent (8.75%) per annum from the Purchase Price Date until the same is paid in full. All interest calculations hereunder shall be computed on the basis of a 360-day year comprised of twelve (12) thirty (30) day months, shall compound daily, and shall be payable in accordance with the terms of this Note. This Secured Convertible Promissory Note (this “Note”) is issued and made effective as of October 9, 2026 (the “Effective Date”). This Note is issued pursuant to that certain Securities Purchase Agreement dated October 9, 2026 by and between Borrower and Le…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.